COPRF News and Press, Copper One

TORONTO, Nov. 14, 2022 (GLOBE NEWSWIRE) -- Medivolve Inc. (“ Medivolve ” or the “ Company “) (NEO: MEDV) (OTC: COPRF) (FRA: 4NC), a healthcare technology and services company, has began its transition towards other service offerings outside of COV...

TORONTO, Aug. 24, 2022 (GLOBE NEWSWIRE) -- Medivolve Inc. (“ Medivolve ” or the “ Company ”) (NEO: MEDV; OTC: COPRF; FRA: 4NC) is pleased to announce the launch of an investor marketing campaign to raise awareness of the Company in the investing community...

Medivolve press release ( OTCPK:COPRF ): 1H net loss was $7.41M in the six months ended June 30, 2022, compared to $18.68M over the prior six months ended June 30, 2021. An increase of 5,056%, cash on hand was $5.79M as at June 30, 2022, compared to $0.11M as at December ...

TORONTO, Aug. 15, 2022 (GLOBE NEWSWIRE) -- Medivolve Inc. (“ Medivolve ” or the “ Company ”) (NEO: MEDV; OTC: COPRF; FRA: 4NC), a healthcare technology company that seeks to improve the US healthcare system by leveraging a bespoke telehealth platform, cli...

TORONTO, July 26, 2022 (GLOBE NEWSWIRE) -- Medivolve Inc. (“Medivolve” or the “Company”) (NEO:MEDV; OTC:COPRF; FRA:4NC) a healthcare technology and services company, is pleased to provide an update on the Company’s business and operations. The Co...

TORONTO, June 16, 2022 (GLOBE NEWSWIRE) -- Medivolve, Inc. (“ Medivolve ” or the “ Company ”) (NEO: MEDV; OTC: COPRF; FRA:4NC), reports, in accordance with the policies of the NEO Exchange, that the nominees listed in the Management Information Circul...

Medivolve press release (OTCPK:COPRF): Q1 gross profit was $6.41M in the three months ending March 31, 2022, up 518%, compared to $1.05M over the prior three months ending March 31, 2021. Net loss was $1.44M in the three months ending March 31, 2022, an improvement of 86%, compared to $9...

Cash on hand was $8,327,812 as at March 31, 2022, up 7,309% compared to $112,397 as at December 31, 2021. Cash provided by operating activities was $8,211,415 in the three months ending March 31, 2022, compared to cash used by operating activities of $4,382,478 in the prior three mont...

TORONTO, May 03, 2022 (GLOBE NEWSWIRE) -- Medivolve, Inc. (“ Medivolve ” or the “ Company ”) (NEO: MEDV; OTC: COPRF; FRA: 4NC) is pleased to announce its intention to commence a Normal Course Issuer Bid (“ NCIB ”) to buy back common shar...

TORONTO, April 06, 2022 (GLOBE NEWSWIRE) -- Medivolve, Inc. (“ Medivolve ” or the “ Company ”) (NEO: MEDV; OTC: COPRF; FRA:4NC) announced today that Vincent Chen, CPA, has joined the Company as VP of Corporate Development. Mr. Chen is a Chartered Pr...